The Global Structural Heart Devices Market valued at $6.6 billion in 2021 is set to witness a growth rate of 10% in the next 5 years. The rising geriatric population & corresponding rise in the ...

ABT wins FDA approval for its Tendyne TMVR system, offering a minimally invasive mitral valve replacement for high-risk patients with severe MAC.

This week, a number of companies, big and small, shared updates on their cardiovascular technology innovations at EuroPCR ...

The higher stroke risk appears to accrue over time, and researchers say more work is needed to better understand why.

This allows for precision care with less pain, fewer complications and quicker recovery times. Recognised for his ...

Results Tricuspid valve abnormalities were more common in groups 1 and 2 ... decreased pulmonary blood flow with ventricular septal defect and pulmonary stenosis (n = 72). The atria were normally ...

St. Luke’s Heart Team pioneers first EVOQUE tricuspid valve replacement in the region, offering new hope for patients with ...

TriCares today shared results from a first-in-human trial supporting its Topaz transcatheter tricuspid valve replacement ...

Progress with transcatheter tricuspid valve replacement (TTVR) candidate devices Topaz, LuX-Valve Plus, VDyne, and Trisol for ...

The approval is tightly defined: the system will be for patients ineligible for surgery and with anatomy unfavorable for TEER ...

Abbott announced the FDA approved its transcatheter mitral valve replacement system for patients with severe mitral annular ...

The FDA gave the OK for the North Chicago-based medical device maker's Tendyne transcatheter mitral valve replacement.